Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United Kingdom”

PS-002 for the Treatment of IgA Nephropathy in AdultsRecruiting
NCT07182227Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Purespring Therapeutics Limited
Immunoglobulin A (IgA) Nephropathy
United States, United Kingdom
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFRecruiting
NCT07761117Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Heart Failure With Preserved Ejection Fraction (HFpEF) · Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
United States, Argentina, Australia, Austria, Brazil +27 more
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)Active Not Recruiting
NCT04602468Phase 4Updated Sep 9, 2026
Sponsor: Royal College of Surgeons, Ireland
Cystic Fibrosis · Cystic Fibrosis Liver Disease · Cystic Fibrosis in Children · Adherence, Medication
Ireland, United Kingdom
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruiting
NCT06948318Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Immune Thrombocytopenic Purpura (ITP)
United States, Australia, Bulgaria, China, Croatia +10 more
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightActive Not Recruiting
NCT05726227Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Obesity
United States, Austria, Belgium, Denmark, Germany +5 more
Long-term Extension of GTX-102 in Angelman SyndromeActive Not Recruiting
NCT06415344Phase 3Updated Sep 9, 2026
Sponsor: Ultragenyx Pharmaceutical Inc
Angelman Syndrome
United States, Australia, Canada, France, Germany +3 more
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein ThrombosisRecruiting
NCT05701917NAUpdated Sep 9, 2026
Sponsor: Inari Medical
Venous Thromboembolism · Deep Venous Thrombosis · Post-Thrombotic Syndrome
United States, Austria, Finland, Germany, Switzerland +1 more
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular AtrophyActive Not Recruiting
NCT05115110Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Spinal Muscular Atrophy (SMA)
United States, Australia, Belgium, Canada, Croatia +7 more
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT04928846Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)Recruiting
NCT07306832Phase 1Updated Sep 9, 2026
Sponsor: AbbVie
Acute Myeloid Leukemia
United States, Australia, France, Italy, South Korea +2 more
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory DyslipidemiasRecruiting
NCT07491172Phase 1Updated Sep 9, 2026
Sponsor: CRISPR Therapeutics AG
Cardiovascular · Metabolic Disease · Dyslipidemias · Lipid Disorder
United States, Australia, New Zealand, United Kingdom
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.Recruiting
NCT07511205Phase 1Updated Sep 9, 2026
Sponsor: AstraZeneca
Healthy Participants · Obesity
United States, United Kingdom
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or RectumNot Yet Recruiting
NCT07811193Phase 2Updated Sep 9, 2026
Sponsor: Vividion Therapeutics, Inc.
Colorectal Adenocarcinoma
United States, Argentina, Belgium, Brazil, China +16 more
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)Active Not Recruiting
NCT04663347Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Genmab
Diffuse Large B-Cell Lymphoma · Follicular Lymphoma
United States, Australia, Belgium, Czechia, Denmark +8 more
Chemo Brain Prehab ProjectRecruiting
NCT07341217NAUpdated Sep 9, 2026
Sponsor: Dr. Chris Gaffney
Colorectal Cancer · Older Adults (60 - 85 Years Old) · Physically Inactive · Chemotherapy
United Kingdom
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerRecruiting
NCT05386108Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Stemline Therapeutics, Inc.
Breast Neoplasms · Brain Neoplasms · Neoplasms by Site · Neoplasms
United States, Belgium, France, Germany, Greece +5 more
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesRecruiting
NCT07648264Phase 3Updated Sep 9, 2026
Sponsor: CSL Behring
Secondary Immune Deficiency
United States, Belgium, Canada, Czechia, Denmark +6 more
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)Recruiting
NCT07549412Phase 3Updated Sep 9, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +11 more
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)Recruiting
NCT07218029Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
United States, Argentina, Australia, Belgium, Brazil +22 more
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)Recruiting
NCT06667700Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Coronavirus Disease (COVID-19)
United States, Argentina, Brazil, Bulgaria, Colombia +19 more
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)Active Not Recruiting
NCT07157254Phase 2Updated Sep 9, 2026
Sponsor: Ultragenyx Pharmaceutical Inc
Angelman Syndrome
United States, Argentina, Brazil, France, Israel +3 more
Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)Completed
NCT02998710N/AUpdated Sep 9, 2026
Sponsor: Travere Therapeutics, Inc.
Homocystinuria Due to CBS Deficiency
United States, Ireland, Qatar, United Kingdom
Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)Terminated
NCT05683860Phase 1, Phase 2Updated Sep 9, 2026
Sponsor: Wave Life Sciences USA, Inc.
Amyotrophic Lateral Sclerosis · Frontotemporal Dementia
Netherlands, United Kingdom
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney DiseaseRecruiting
NCT05312879Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Vertex Pharmaceuticals Incorporated
Proteinuric Kidney Disease
United States, Belgium, Brazil, Canada, Colombia +8 more
Establishing the Incidence of Tako-tsubo Cardiomyopathy in ScotlandRecruiting
NCT03299569N/AUpdated Sep 9, 2026
Sponsor: University of Aberdeen
Takotsubo Cardiomyopathy · Myocardial Infarction
United Kingdom

Previous page Next page